Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Blood Cancer Journal
|
November 4, 2022
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome
Rami S Komrokji, Avani M Singh, Najla Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 4, 2022
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms
Franco Castillo Tokumori, Najla Al Ali, Onyee Chan, et al.
Blood Advances
|
July 30, 2020
Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant
Seongseok Yun, Onyee Chan, Daniel Kerr, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 9, 2023
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia
Akriti G Jain, Somedeb Ball, Luis E Aguirre, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 27, 2022
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia
Dasom Lee, Akriti G Jain, Yehuda Deutsch, et al.
Blood Advances
|
April 14, 2023
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
Rami S Komrokji, Luis E Aguirre, Najla H Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 23, 2020
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype
Zaker I Schwabkey, Najla Al Ali, Onyee Chan, et al.
Cancer
|
August 9, 2022
Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates
Andrew T Kuykendall, Qianxing Mo, David A Sallman, et al.
Annals of Hematology
|
November 29, 2023
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities
Nathan P Horvat, Enas F Abdallah, Zhuoer Xie, et al.
Annals of Hematology
|
September 7, 2024
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia
Akriti G Jain, Virginia O Volpe, Chen Wang, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Blood Cancer Journal
|
November 4, 2022
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome
Rami S Komrokji, Avani M Singh, Najla Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 4, 2022
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms
Franco Castillo Tokumori, Najla Al Ali, Onyee Chan, et al.
Blood Advances
|
July 30, 2020
Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant
Seongseok Yun, Onyee Chan, Daniel Kerr, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 9, 2023
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia
Akriti G Jain, Somedeb Ball, Luis E Aguirre, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 27, 2022
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia
Dasom Lee, Akriti G Jain, Yehuda Deutsch, et al.
Blood Advances
|
April 14, 2023
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
Rami S Komrokji, Luis E Aguirre, Najla H Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 23, 2020
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype
Zaker I Schwabkey, Najla Al Ali, Onyee Chan, et al.
Cancer
|
August 9, 2022
Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates
Andrew T Kuykendall, Qianxing Mo, David A Sallman, et al.
Annals of Hematology
|
November 29, 2023
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities
Nathan P Horvat, Enas F Abdallah, Zhuoer Xie, et al.
Annals of Hematology
|
September 7, 2024
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia
Akriti G Jain, Virginia O Volpe, Chen Wang, et al.
Page
of 8